We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Augmedix Inc | NASDAQ:AUGX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0495 | -4.95% | 0.95 | 0.95 | 0.96 | 1.0294 | 0.90 | 1.01 | 816,510 | 00:59:44 |
The fireside chat will be held at 11 a.m. PT / 2 p.m. ET. The webcast can be accessed live or as an archived replay on the Company’s Investor Relations website at https://ir.augmedix.com/.
Company management will also be participating in one-on-one investor meetings at the conference. To schedule a meeting, please submit a request on the conference website, contact your Citizens JMP representative, or email Augmedix’s IR team FNK IR at investors@augmedix.com.
About Augmedix
Augmedix (Nasdaq: AUGX) delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners.
Augmedix is on a mission to help clinicians and patients form a human connection by seamlessly integrating our technology at the point of care. Augmedix’s proprietary platform digitizes natural clinician-patient conversations, which are converted into comprehensive medical notes and structured data in real-time. The company’s platform uses automatic speech recognition, and natural language processing, including large language models, to generate accurate and timely medical notes that are transferred into the EHR.
Augmedix’s products relieve clinicians of administrative burden, in turn, reducing burnout, increasing clinician efficiency, and improving patient access. Through Augmedix’s proprietary platform and bi-directional communication channel, Augmedix is ideally suited to serve as the vehicle for change at the point of care.
Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit www.augmedix.com.
Contact Information
Investors:Matt Chesler, CFAFNK IR(646) 809-2183augx@fnkir.cominvestors@augmedix.com
Media:Kaila GrafemanAugmedixpr@augmedix.com
1 Year Augmedix Chart |
1 Month Augmedix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions